delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD)

DRUG2 trials

Sponsors

Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal, King's College London

Conditions

Cannabis IntoxicationHuntington's Disease

Phase 2

Neuroprotection by Cannabinoids in Huntington's Disease

CompletedNCT01502046

Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y CajalHuntington's Disease

Start: 2011-09-30End: 2012-06-30Updated: 2013-02-01

Unknown Phase

Exploring The Effect Of Cannabidiol On Cannabis Tolerance Using A Novel Vaporiser Device In Heavy Users (Stage 1)

Not yet recruitingNCT07471347

King's College LondonCannabis Intoxication

Start: 2026-03-01End: 2026-12-01Target: 10Updated: 2026-03-13

Related Papers

A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington's disease.

2016-05-0993 citations